PEPTIDE EPOXYCETONES DESTINEES A L'INHIBITION DE PROTEASOME
- 专利权人:
- INC.;ONYX THERAPEUTICS
- 发明人:
- 申请号：
- EP07809745.8
- 公开号：
- EP2041158B1
- 申请日:
- 2007.06.19
- 申请国别(地区):
- EP
- 年份:
- 2013
- 代理人:
- 摘要：
- One aspect of the invention relates to inhibitors of formula (I) that preferentially inhibit immunoproteasome activity over constitutive proteasome activity. In certain embodiments, the invention relates to the treatment of immune related diseases, comprising administering a compound of the invention. In certain embodiments, the invention relates to the treatment of cancer, comprising administering a compound of the invention.
- 来源网站：
- 中国工程科技知识中心
相关发明人
相关专利
- isolated polypeptide with endopeptidase activity, composition, method for producing the polypeptide, preparing a protein hydrolyzate, and for preparing a food protein hydrolyzate, and uses of the polypeptide or composition, and a bacterial trypsin-like endopeptidase
- ASPARAGINE ENDOPEPTIDASE (AEP) INHIBITORS FOR MANAGING CANCER AND COMPOSITIONS RELATED THERETO
- DÉRIVÉS D'ACIDE PHOSPHONIQUE BUTANOÏQUE DE BISPHÉNOL SUBSTITUÉS EN QUALITÉ D'INHIBITEURS DE NEP (ENDOPEPTIDASE NEUTRE)
- INHIBITEURS D'ENDOPEPTIDASE NEUTRE (NEP) ET D'ENDOPEPTIDASE HUMAINE SOLUBLE (HSEP) DESTINÉS À LA PROPHYLAXIE ET AU TRAITEMENT DE MALADIES OCULAIRES
- TRAITEMENT DE MALADIES NEURODÉGÉNÉRATIVES À L'AIDE D'INHIBITEURS D'ASPARAGINE ENDOPEPTIDASE (AEP) ET COMPOSITIONS ASSOCIÉES
